Those kind of returns are what I like to see. Only activity I've had is buying MPTO, love the chart and it is at the far low end.
Those kind of returns are what I like to see. Only activity I've had is buying MPTO, love the chart and it is at the far low end.
Originally Posted by tony
http://community.smallcapnetwork.com...p/mid/3/id/96/
been seeing some bearish talk in regards to BIEL. Talking about a target price of $.056. Not quite what I expected considering their financial audit is coming up and possible fda approval. Would this be a good example of just looking at the technical's rather than the whole picture (i.e. what is going on behind the numbers?)?
I've transitioned to doing that (checking actual data than hype) more often lately.. I figured BIEL would have had the run up affect but I am starting to realize the more something is pumped and expectations are high, the hype is already factored into the price. Today I sold off 2/3rds of my holding of BIEL, it may have the expected run up but the pumping of it has become a turn off for me. 8/10 stocks that I've followed that have been pumped end up not so great, others that kind of flew under the radar with good data typically had the big break outs.. of which pumpers usually jump on the banwagon after the real profits have been taken.
Not to say anything bad about BIEL but I've seen it numerous times this year. BIEL is now a spec play, MPTO has been added long term for the potential of a couple of its subsidiaries.
I sold all my BIEL a couple of weeks ago and I don't think I'll touch it again.
If they don't get approved than their technology doesn't work or is not safe, which means they don't have a business. It's that simple. What kind of technical analysis or forecasting method takes this into account???Technical analysis and penny stocks don't go together IMO. Only fundamentals and hype(!!!). Charts of penny stocks defy all laws of physics lol.
All of BIELs planned products are different applications of the same technology, they don't have a pipeline of different drugs with different technologies like other biotechs. All their eggs are in one basket. So if it doesn't pass, they don't have a product and have nothing to fall back on and it's game over.
2 or 3 months ago I was writing about how I don't like the fundies on BIEL in this very same thread. Then I gave in to all the hype and actually bought it lol. Not doing that again.
i was referring to how the analysis didnt simply took current numbers as is into account without reference for fda approval as even being on the horizon. does that make sense? anyways i get what you guys are saying.If they don't get approved than their technology doesn't work or is not safe, which means they don't have a business. It's that simple. What kind of technical analysis or forecasting method takes this into account???
like i stated earlier, euro is making a nice evening bounce. def was worth the buy even if i was a bit premature of the dollar peak at 1.4850
Posting Permissions
Reply With Quote